| 注册
首页|期刊导航|临床医学工程|血必净、奥曲肽及乌司他丁联合治疗对急性重症胰腺炎患者免疫功能及炎性反应的影响

血必净、奥曲肽及乌司他丁联合治疗对急性重症胰腺炎患者免疫功能及炎性反应的影响

王洁 赵翠 尹晗

临床医学工程2024,Vol.31Issue(12):1521-1522,2.
临床医学工程2024,Vol.31Issue(12):1521-1522,2.DOI:10.3969/j.issn.1674-4659.2024.12.1521

血必净、奥曲肽及乌司他丁联合治疗对急性重症胰腺炎患者免疫功能及炎性反应的影响

Impact of Combined Treatment of Xuebijing,Octreotide and Ulinastatin on Immune Function and Inflammatory Response of Patients with Severe Acute Pancreatitis

王洁 1赵翠 1尹晗1

作者信息

  • 1. 商丘市第一人民医院急诊重症监护室,河南 商丘 476000
  • 折叠

摘要

Abstract

Objective To explore the clinical effect of Xuebijing,octreotide combined with ulinastatin in the treatment of patients with severe acute pancreatitis.Methods 78 patients with severe acute pancreatitis were randomly divided into two groups.The reference group was treated with octreotide+ulinastatin,and the study group was treated with Xuebijing+octreotide+ulinastatin.The immune function,inflammatory response and complications were compared between the two groups.Results After 2 weeks of treatment,the levels of CD4+and CD4+/CD8+in the study group were higher than those in the reference group,the levels of CD8+and serum IL-6,TNF-α and CRP were lower than those in the reference group,and the total incidence of complications was lower than that in the reference group(P<0.05).Conclusions The combined treatment of Xuebijing,octreotide and ulinastatin can obviously regulate the cellular immune function of patients with severe acute pancreatitis,reduce the inflammatory response and reduce the occurrence risk of complications.

关键词

急性重症胰腺炎/血必净/奥曲肽/乌司他丁/免疫功能/炎性反应

Key words

Severe acute pancreatitis/Xuebijing/Octreotide/Ulinastatin/Immune function/Inflammatory response

分类

医药卫生

引用本文复制引用

王洁,赵翠,尹晗..血必净、奥曲肽及乌司他丁联合治疗对急性重症胰腺炎患者免疫功能及炎性反应的影响[J].临床医学工程,2024,31(12):1521-1522,2.

临床医学工程

1674-4659

访问量4
|
下载量0
段落导航相关论文